121 related articles for article (PubMed ID: 36517429)
21. Differentiation between pancreatic metastases from clear cell renal cell carcinoma and pancreatic neuroendocrine tumor using double-echo chemical shift imaging.
Lyu HL; Cao JX; Wang HY; Wang ZB; Hu MG; Ma L; Wang YW; Ye HY
Abdom Radiol (NY); 2018 Oct; 43(10):2712-2720. PubMed ID: 29500651
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic test accuracy of ADC values for identification of clear cell renal cell carcinoma: systematic review and meta-analysis.
Tordjman M; Mali R; Madelin G; Prabhu V; Kang SK
Eur Radiol; 2020 Jul; 30(7):4023-4038. PubMed ID: 32144458
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic accuracy of segmental enhancement inversion for the diagnosis of renal oncocytoma using biphasic computed tomography (CT) and multiphase contrast-enhanced magnetic resonance imaging (MRI).
Schieda N; Al-Subhi M; Flood TA; El-Khodary M; McInnes MD
Eur Radiol; 2014 Nov; 24(11):2787-94. PubMed ID: 25027841
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic Value Analysis of Multi-Slice Helical Computed Tomography Reconstruction Parameters Combined with 3.0 T Magnetic Resonance in Clear Cell Renal Cell Carcinoma.
Guo H; Li J; Lu X
Arch Esp Urol; 2023 Oct; 76(8):570-578. PubMed ID: 37960956
[TBL] [Abstract][Full Text] [Related]
25. Differentiating papillary type I RCC from clear cell RCC and oncocytoma: application of whole-lesion volumetric ADC measurement.
Paschall AK; Mirmomen SM; Symons R; Pourmorteza A; Gautam R; Sahai A; Dwyer AJ; Merino MJ; Metwalli AR; Linehan WM; Malayeri AA
Abdom Radiol (NY); 2018 Sep; 43(9):2424-2430. PubMed ID: 29520425
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of renal oncocytoma and renal clear cell carcinoma using relative CT enhancement ratio.
Ren A; Cai F; Shang YN; Ma ES; Huang ZG; Wang W; Lu Y; Zhang XZ
Chin Med J (Engl); 2015 Jan; 128(2):175-9. PubMed ID: 25591558
[TBL] [Abstract][Full Text] [Related]
27. Differentiation between fat-poor angiomyolipoma and clear cell renal cell carcinoma: qualitative and quantitative analysis using arterial spin labeling MR imaging.
Ye J; Xu Q; Wang SA; Zheng J; Zhu QQ; Dou WQ
Abdom Radiol (NY); 2020 Feb; 45(2):512-519. PubMed ID: 31705246
[TBL] [Abstract][Full Text] [Related]
28. Segmental enhancement inversion at biphasic multidetector CT: characteristic finding of small renal oncocytoma.
Kim JI; Cho JY; Moon KC; Lee HJ; Kim SH
Radiology; 2009 Aug; 252(2):441-8. PubMed ID: 19508984
[TBL] [Abstract][Full Text] [Related]
29. CT-based radiomic model predicts high grade of clear cell renal cell carcinoma.
Ding J; Xing Z; Jiang Z; Chen J; Pan L; Qiu J; Xing W
Eur J Radiol; 2018 Jun; 103():51-56. PubMed ID: 29803385
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of CT appearances in renal oncocytoma and chromophobe renal cell carcinoma.
Wu J; Zhu Q; Zhu W; Chen W; Wang S
Acta Radiol; 2016 Apr; 57(4):500-6. PubMed ID: 25972369
[TBL] [Abstract][Full Text] [Related]
31. Can diffusion-weighted magnetic resonance imaging of clear cell renal carcinoma predict low from high nuclear grade tumors.
Parada Villavicencio C; Mc Carthy RJ; Miller FH
Abdom Radiol (NY); 2017 Apr; 42(4):1241-1249. PubMed ID: 27904923
[TBL] [Abstract][Full Text] [Related]
32. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade.
Rosenkrantz AB; Niver BE; Fitzgerald EF; Babb JS; Chandarana H; Melamed J
AJR Am J Roentgenol; 2010 Nov; 195(5):W344-51. PubMed ID: 20966299
[TBL] [Abstract][Full Text] [Related]
33. A triple-classification for differentiating renal oncocytoma from renal cell carcinoma subtypes and CK7 expression evaluation: a radiomics analysis.
Yu Z; Ding J; Pang H; Fang H; He F; Xu C; Li X; Ren K
BMC Urol; 2022 Sep; 22(1):147. PubMed ID: 36096829
[TBL] [Abstract][Full Text] [Related]
34. Renal Mass Imaging with MRI Clear Cell Likelihood Score: A User's Guide.
Shetty AS; Fraum TJ; Ballard DH; Hoegger MJ; Itani M; Rajput MZ; Lanier MH; Cusworth BM; Mehrsheikh AL; Cabrera-Lebron JA; Chu J; Cunningham CR; Hirschi RS; Mokkarala M; Unteriner JG; Kim EH; Siegel CL; Ludwig DR
Radiographics; 2023 Jul; 43(7):e220209. PubMed ID: 37319026
[TBL] [Abstract][Full Text] [Related]
35. Value of radiomics in differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.
Li Y; Huang X; Xia Y; Long L
Abdom Radiol (NY); 2020 Oct; 45(10):3193-3201. PubMed ID: 31664486
[TBL] [Abstract][Full Text] [Related]
36. Ratio of maximum to minimum tumor diameter can predict the pathology type of renal cell carcinoma before surgery.
Jiang W; Wang D; Shi H; Shang B; Wen L; Zhang L; Zhang J; Zhang H; Zheng S; Shou J
Tumori; 2021 Feb; 107(1):64-70. PubMed ID: 32597325
[TBL] [Abstract][Full Text] [Related]
37. Analysis of dual energy spectral CT and pathological grading of clear cell renal cell carcinoma (ccRCC).
Wei J; Zhao J; Zhang X; Wang D; Zhang W; Wang Z; Zhou J
PLoS One; 2018; 13(5):e0195699. PubMed ID: 29715308
[TBL] [Abstract][Full Text] [Related]
38. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
39. FDG PET/CT and CT Findings of Renal Cell Carcinoma With Sarcomatoid Differentiation.
Zhu H; Zhao S; Zuo C; Ren F
AJR Am J Roentgenol; 2020 Sep; 215(3):645-651. PubMed ID: 32755159
[No Abstract] [Full Text] [Related]
40. The predictive and prognostic values of serum amino acid levels for clear cell renal cell carcinoma.
Zhang F; Ma X; Li H; Guo G; Li P; Li H; Gu L; Li X; Chen L; Zhang X
Urol Oncol; 2017 Jun; 35(6):392-400. PubMed ID: 28188089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
